Latest

    cxvascular

    Medical therapy improvements mean “the time has come” to reconduct prior...

    ESRD strongly associated with adverse limb events in new study

    CX 2023 seeks consensus in “rapidly” progressing venous field

    BASIL-2

    CX 2023 highlight: The BASIL-2 trial

    endograft

    Study highlights need for “continuous comparative assessments” to guide endograft treatment...

    Distal embolic protection linked to significantly better outcomes in carotid stenting

    Intravascular ultrasound given “unanimous approval” in consensus document for peripheral procedural...

    EU ministers approve changes to MDR transition timetable

    top 10

    Vascular News’ top 10 most popular stories of February 2023

    filters

    New study demonstrates IVC filters “safe and effective” in treating venous...

    mental health

    “Urgent action needed” to improve implementation of guideline-directed medical therapy for...

    Renal denervation “can reach new shores”

    kidney

    ESC and EAPCI publish renal denervation consensus statement

    Educate, educate, and educate again: The continuing quest for appropriate venous...

    Abbott to acquire Cardiovascular Systems

    UK-COMPASS highlights “extremely good” three-year results for complex aneurysm treatment in...

    UK NVR annual report highlights “extremely high” case ascertainment rates despite...

    Equivalency to clinical practice “varies considerably” across recent carotid intervention trials

    Sex found to be “important variable” in study and treatment of...

    elderly

    Age is just a number: Individual patient data meta-analysis probes safety...

    screening

    AAA screening: UK programme’s 10-year anniversary prompts renewed push for increasing...

    nellix

    ESVS AAA guidelines alert recommends “enhanced surveillance” in patients treated with...

    “A very grey area”: EVOCC trial addresses best treatment option for...

    financing

    Funding secured to advance development of Pulse IVL system

    Cardiovascular Systems announces US FDA 510(k) submission of Innova Vascular’s thrombectomy...

    Hypotension and AV access thrombosis: Causation or just association?

    ReCor appoints Lara Barghout to lead commercialisation of Paradise renal denervation...

    vascular

    Markus Steinbauer

    VSGBI President’s Symposium spotlights data-driven financial incentives for PAD revascularisation

    New study comparing DCBs to bare metal stents in femoropopliteal lesions...

    New data back Indigo aspiration system as “first-line treatment” for acute...

    First data from BEST-CLI bring surgical bypass into the forefront of...

    Endarterectomy and TCAR “continue to show superior outcomes” to transfemoral stenting

    Endologix reports five-year data of the LEOPARD trial for the treatment...

    Disrupt

    Disrupt PAD III observational study results confirm safety and effectiveness of...

    amputation-free

    End-stage CLTI: Deep vein arterialisation procedure demonstrates amputation-free survival rate of...

    SurVeil

    SurVeil DCB demonstrates sustained durability of safety, efficacy endpoints in TRANSCEND

    DCBs

    New analysis: Four multicentre trials support primary use of DCBs over...

    BioMimics

    “Excellent” three-year results presented for the BioMimics 3D stent in longer...

    Coselli

    Joseph S Coselli

    Alexander Zimmermann

    vascular

    Palma Shaw

    Michael Jenkins

    Joseph E Bavaria

    Ali AbuRahma

    Julie Ann Freischlag

    Load more

    Jon Boyle

    vascular

    Markus Steinbauer

    Coselli

    Joseph S Coselli

    Vascular News

    Write to us
    Editor: Jocelyn Hudson [email protected]
    Advertising: Shilpa Suthar [email protected]


    United Kingdom:

    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: [email protected]

    United States:

    BIBA Medical, North America
    155 North Wacker Drive, Suite 4250, Chicago, IL 60606
    TEL: +1 949 723 9309
    Email: [email protected]

    Terms and Conditions | Privacy Policy